Altitude
14
3
4
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Adaptation of Lung Transplant Recipients at Extreme Altitude
Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude
The Psychophysiological Effect of Simulated and Terrestrial Altitude
Determination of Iron Absorption and Losses in People Living at High Altitude to Investigate the Requirements in This Population Group Using a Newly Developed Technique
Hypoxia, Appetite, and Energy Intake in Young Female Adults
Short-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis
Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude
Endurance Performance at Altitude
Effects of Mild Hypobaric Hypoxia on Sleep and Post-sleep Performance
Cardiopulmonary Adaptation of Short Term Exposure to High Altitude in Fontan Patients: Swiss Fontan & ALtitude COllaboratioN (FALCON) Study
Tübingen High Altitude Ophthalmology Study
Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects.
Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude
Effect of Bosentan on Exercise Capacity at High Altitude